ABT
NYSEABBOTT LABORATORIES
Health Care, Health Care Equipment
$107.81
close 7 Aug 2026
-17.93%
52-week change
$187.78B
market cap
$81.97
$137.49
52-week range
Valuation
Market cap$187.78B
P/E (TTM / 5y avg)30.20x27.83x
Forward P/E (FY2026 / FY2027)19.54x17.78x
PEG (TTM / fwd)—1.98
P/S (TTM)4.16x
P/B3.61x
EV/EBITDA (TTM)23.41x
FCF yield (TTM)3.93%
Cash flow & dividend
FCF (TTM)$7.38B
FCF per share (TTM)$4.24
FCF margin (TTM)16.35%
Dividend yield (indicated / 5y avg)2.34%1.90%
Annualized dividend$2.52
Payout ratio (EPS / FCF)66.73%56.76%
Growth & quality
Revenue YoY, latest Q+7.78%
Diluted EPS YoY, latest Q-19.74%
Operating margin (TTM)17.07%
Net margin (TTM)13.91%
ROE (latest FY)12.51%
Net debt / EBITDA (TTM)2.97
Interest coverage (TTM)14.38
Price
-12.39%-2.62%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +5.08%10Y CAGR +8.07%
Diluted EPS
5Y CAGR +8.27%10Y CAGR +2.45%
FCF per share
5Y CAGR +5.78%10Y CAGR +13.15%
Operating cash flow
5Y CAGR +3.90%10Y CAGR +12.42%
Free cash flow
5Y CAGR +5.26%10Y CAGR +14.82%
Dividends per share
5Y CAGR +10.51%10Y CAGR +9.44%
Payout ratio
FCF payout ratio
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -0.50%10Y CAGR +1.48%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date13 Oct 2026bmo
EPS estimate$1.43
Revenue estimate$13.13B
Last reported
Date—
EPS——
Revenue——